A synthetic product production system is provided with: a synthesis plant for producing a synthetic product by synthesizing a hydrogen-containing gas and carbon dioxide; and a carbon dioxide supply line for supplying the carbon dioxide to the synthesis plant from a recovery and storage plant including a recovery device for recovering the carbon dioxide from a carbon dioxide-containing gas and an injection facility for fixing the recovered carbon dioxide into a stratum.

A process for producing syngas including at least H.sub.2 and CO. The process includes the steps of a) generating a transition metal carbide by reacting a corresponding transition metal oxide with a fuel to produce a stream of syngas; and b) combining the transition metal carbide with oxygen to oxidize the transition metal carbide to regenerate the corresponding transition metal oxide, thereby producing a gas output comprising at least one or more oxidized carbon compounds and heat for autothermal operation.

A process for producing syngas including at least H.sub.2 and CO. The process includes the steps of a) generating a transition metal carbide by reacting a corresponding transition metal oxide with a fuel to produce a stream of syngas; and b) combining the transition metal carbide with oxygen to oxidize the transition metal carbide to regenerate the corresponding transition metal oxide, thereby producing a gas output comprising at least one or more oxidized carbon compounds and heat for autothermal operation.

The present invention relates to a stable crystal form, i.e. form A, of 2-tert-butyl-4-methoxyphenol, and to a new preparation method for the 2-tert-butyl-4-methoxyphenol; and the use of the 2-tert-butyl-4-methoxyphenol and the stable crystal form thereof, i.e. form A, in preparing antitumor drugs or immunomodulator drugs. The stable crystal form, i.e. form A, as expressed by a powder X-ray diffraction pattern in an angle of 2θ, using Cu-Kα radiation, has at least 3 absorption peaks selected from the following positions: 6.27±0.10, 6.94±0.10, 12.27±0.10, 13.36±0.10, 14.01±0.10, 14.79±0.10, 15.31±0.10, 17.05±0.10, 18.30±0.10, 19.00±0.10, 20.47±0.10, 20.98±0.10, 22.37±0.10, 23.68±0.10, 24.55±0.10, 25.37±0.10, 30.83±0.10, 33.12±0.10, 40.50±0.10, 42.81±0.10.

The present invention relates to a stable crystal form, i.e. form A, of 2-tert-butyl-4-methoxyphenol, and to a new preparation method for the 2-tert-butyl-4-methoxyphenol; and the use of the 2-tert-butyl-4-methoxyphenol and the stable crystal form thereof, i.e. form A, in preparing antitumor drugs or immunomodulator drugs. The stable crystal form, i.e. form A, as expressed by a powder X-ray diffraction pattern in an angle of 2θ, using Cu-Kα radiation, has at least 3 absorption peaks selected from the following positions: 6.27±0.10, 6.94±0.10, 12.27±0.10, 13.36±0.10, 14.01±0.10, 14.79±0.10, 15.31±0.10, 17.05±0.10, 18.30±0.10, 19.00±0.10, 20.47±0.10, 20.98±0.10, 22.37±0.10, 23.68±0.10, 24.55±0.10, 25.37±0.10, 30.83±0.10, 33.12±0.10, 40.50±0.10, 42.81±0.10.

A method includes: providing a mixture including at least one alkyl tosylate and a Grignard reagent; and reacting the at least one alkyl tosylate with the Grignard reagent in a C—C coupling reaction mechanism to form a branched aliphatic alcohol.

A method includes: providing a mixture including at least one alkyl tosylate and a Grignard reagent; and reacting the at least one alkyl tosylate with the Grignard reagent in a C—C coupling reaction mechanism to form a branched aliphatic alcohol.

The present invention relates to a method for preparing monomers via depolymerisation from lignocellulose-containing biomass.

The present invention relates to a method for preparing monomers via depolymerisation from lignocellulose-containing biomass.

The present invention relates to a method for preparing monomers via depolymerisation from lignocellulose-containing biomass.